§Growth HormoneResearch protocol
GHRP-2.
GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors[1]. Clinical studies predominant...
Vial Size:
Research Use Only. PeptiJournal supports private research documentation and calculation support. It does not provide medical advice, human-use directions, or claims of safety or effectiveness.
Cited diluent3 mL
Cited protocol example—review and confirm.
Reference syringe capacity
Concentration
1,666.667
mcg/mL
Per event
100 mcg
7 events/week
Vials projected
5
16 cited weeks
Calculated volume reference
6.0 units
1mL syringe
GHRP-2
6.0u(0.060 mL)
Daily
Cited protocol & reconstitution guide
Source-backed reference fields by phase, including any volume fields authored in the cited guide.
Weeks 1–2
100 mcg
Units / volume6 units (0.06 mL)
Weeks 3–4
150 mcg
Units / volume9 units (0.09 mL)
Weeks 5–8
200 mcg
Units / volume12 units (0.12 mL)
Weeks 9–12
200 mcg
Units / volume12 units (0.12 mL)
Weeks 13–16
200 mcg
Units / volume12 units (0.12 mL)
| Phase | Daily reference amount | Units / volume |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 150 mcg | 9 units (0.09 mL) |
| Weeks 5–8 | 200 mcg | 12 units (0.12 mL) |
| Weeks 9–12 | 200 mcg | 12 units (0.12 mL) |
| Weeks 13–16 | 200 mcg | 12 units (0.12 mL) |
Reconstitution by vial size
Calculated volume for each cited phase and vial variant. The highlighted column matches the selection above.
| Phase | 5 mg 3 mL water | 10 mg 3 mL water |
|---|---|---|
| Weeks 1–2 | 6 u 0.06 mL | 3 u 0.03 mL |
| Weeks 3–4 | 9 u 0.09 mL | 4.5 u 0.04 mL |
| Weeks 5–8 | 12 u 0.12 mL | 6 u 0.06 mL |
| Weeks 9–12 | 12 u 0.12 mL | — |
| Weeks 13–16 | 12 u 0.12 mL | — |
Cited guide source: View source